
As a part of our mission, the Alliance for Regenerative Medicine (ARM) is committed to serving our membership in enabling the development of, and global access to, Cell & Gene Therapies. Through ARM’s Managed Growth Working Group, an initiative aimed at identifying how ARM can refine and expand its work to better serve our member organization, ARM kicked off its Asia-Pacific (APAC) geographic expansion strategy in 2024. Based on ARM’s recent sector data, the APAC region is second to North America in the number of CGT developers, clinical trials, and investment, and is growing at twice the rate of North America and Europe.
To support the APAC geographic expansion strategy, we are excited to announce our upcoming APAC Virtual Summit: Cell & Gene Therapy Horizons, a half-day virtual workshop exploring the rapidly evolving landscape of cell and gene therapy (CGT) across the APAC region. This summit will provide insights into CGT development, regulations, and commercialization in APAC.
Participants will gain access to presentations, in-depth discussions and expert-led panels covering:
Looking to gain extensive exposure to hundreds of top decision makers in the CGT sector? Contact Laura Stringham at lstringham@alliancerm.org to learn more about the benefits of supporting this workshop.
Please contact Josephine Lembong at jlembong@alliancerm.org